Our mission is to develop and make globally available the first therapy targeting a root cause of preeclampsia.
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.
Learn About Our WorkMeet Our Team
Read our latest news
Learn More
Contact Us
50 Beharrell St, Unit B
Concord, MA 01742